Grand Pharmaceutical Group Limited (HKG: 0512)

Market Cap	15.55B
Revenue (ttm)	10.59B
Net Income (ttm)	2.41B
Shares Out	3.50B
EPS (ttm)	0.69
PE Ratio	6.44
Forward PE	7.40
Dividend	0.26 (5.86%)
Ex-Dividend Date	Jun 6, 2024

Volume	1,367,103
Open	4.420
Previous Close	4.440
Day's Range	4.270 - 4.450
52-Week Range	3.170 - 5.310
Beta	0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 19, 2024

About Grand Pharmaceutical Group

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additive...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 10,534
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0512

Financial Performance

In 2023, Grand Pharmaceutical Group's revenue was 10.53 billion, an increase of 10.12% compared to the previous year's 9.56 billion. Earnings were 1.88 billion, a decrease of -9.59%.